Form 4 for LSBK Lake Shore Bancorp, Inc. /MD/
Accepted 2026-08-25 16:30:03 ET · period of report 2026-08-21 · accession 0001193125-26-365199 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-25 16:30 | 2026-08-21 | LSBK | Werdein Jeffrey M. | EVP-Commercial Division | M - OptEx | $10.62 | +23.1K | 77.4K | +43% | +$245.7K |
| D | 2026-08-25 16:30 | 2026-08-21 | LSBK | Werdein Jeffrey M. | EVP-Commercial Division | F - Tax | $17.25 | -16.5K | 60.9K | -21% | -$285.1K |
| D | 2026-08-25 16:30 | 2026-08-21 | LSBK | Werdein Jeffrey M. | EVP-Commercial Division | M - OptEx | $0.00 | -23.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-21 | M | A | 23,132 | $10.62 | 77,387 | D | — | — | (F1) Exercise price amounted to $10.61342469, which represents the original exercise price of $14.38, updated for the 1.3549 to 1.00 exchange in connection with the Company's mutual to stock conversion, so that the aggregate cost of the options remained unchanged after conversion. This and previous filings present the exercise price rounded up to the nearest whole penny, or $10.62. No fractional shares were issued to the reporting person. |
| 2 | Common | Common Stock | 2026-08-21 | F | D | 16,525 | $17.25 | 60,862 | D | — | — | (F2) The number of shares reported as disposed of represents shares withheld by the issuer through net settlement to satisfy the exercise price of the option award and the tax liability incident to the withholding of shares. No shares were sold in the open market. (F3) Includes 3,025 shares of unvested restricted stock that were granted on March 18, 2026 and vest in four equal installments beginning on the first anniversary of the grant. (F4) Includes 3,063 remaining shares of unvested restricted stock that were granted on March 12, 2025 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant. (F5) Includes 1,717 remaining shares of unvested restricted stock that were granted on April 23, 2024 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant. |
| 3 | Derivative | Option (right to buy) | 2026-08-21 | M | D | 23,132 | $0.00 | 0 | D | $10.62 · — to 2026-10-21 | 23,132 Common Stock | (F1) Exercise price amounted to $10.61342469, which represents the original exercise price of $14.38, updated for the 1.3549 to 1.00 exchange in connection with the Company's mutual to stock conversion, so that the aggregate cost of the options remained unchanged after conversion. This and previous filings present the exercise price rounded up to the nearest whole penny, or $10.62. No fractional shares were issued to the reporting person. (F8) Options are fully vested. |